Visualitza per autor "Alarcón, E."
Ara mostrant els elements 1-1 d 1
-
BEECH: a dose-finding run-in followed by a randomised phase II study assessing the efficacy of AKT inhibitor capivasertib (AZD5363) combined with paclitaxel in patients with estrogen receptor-positive advanced or metastatic breast cancer, and in a PIK3CA mutant sub-population
Turner, N. C.; Alarcón, E.; Armstrong, A. C.; Philco, M.; López Chuken, Y. A.; Sablin, Marie-Paule; Antunes de Melo Oliveira, Ana Mafalda (Oxford University Press, 2019-05-01)